Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease
| العنوان: | Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease |
|---|---|
| المؤلفون: | Antonio Tello-Montoliu, Juan M. Ruiz-Nodar, Miriam Sandín-Rollán, Juan Gabriel Martínez Martínez, Miriam Quintana-Giner, Esteban Orenes-Piñero, Nuria Vicente-Ibarra, José Miguel Rivera-Caravaca, Luna Carrillo-Alemán, Vicente Pernias-Escrig, Manuel J Macías-Villanego, María Asunción Esteve-Pastor, Teresa Lozano, Francisco Marín, A Veliz-Martinez |
| المصدر: | Minerva Medica. 110 |
| بيانات النشر: | Edizioni Minerva Medica, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Male, Ticagrelor, medicine.medical_specialty, Acute coronary syndrome, Aftercare, Coronary Disease, Hemorrhage, Comorbidity, Kaplan-Meier Estimate, Tertiary Care Centers, Coronary artery disease, Peripheral Arterial Disease, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, Prospective Studies, cardiovascular diseases, Acute Coronary Syndrome, Prospective cohort study, Stroke, Proportional Hazards Models, Metabolic Syndrome, business.industry, Smoking, General Medicine, medicine.disease, Clopidogrel, Drug Utilization, Spain, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, business, Prasugrel Hydrochloride, Platelet Aggregation Inhibitors, Mace, Follow-Up Studies, medicine.drug |
| الوصف: | BACKGROUND Patients with acute coronary syndrome (ACS) and previous cardiovascular disease (CVD) (stroke, peripheral arterial disease [PAD] or coronary artery disease [CAD]) are at high risk of serious events and mortality. Current clinical guidelines recommend new antiplatelet drugs (NADs) for high cardiovascular risk patients with ACS; however, these drugs are underused in different scenarios. METHODS This study included 1717 ACS patients from 3 tertiary hospitals. Of them, 641 (37.33%) suffered from previous CVD: 149 patients with stroke, 154 patients with PAD and 541 patients with CAD. Bleeding, mortality and major adverse cardiac events (MACE) at 1 year of follow-up after hospital discharge were analyzed. RESULTS NADs administration during hospital stay and at discharge was less frequent in patients with previous CVDs (P |
| تدمد: | 1827-1669 0026-4806 |
| DOI: | 10.23736/s0026-4806.19.05859-2 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1994e3e95436576aa5604a09b9ea50e https://doi.org/10.23736/s0026-4806.19.05859-2 |
| رقم الانضمام: | edsair.doi.dedup.....d1994e3e95436576aa5604a09b9ea50e |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 18271669 00264806 |
|---|---|
| DOI: | 10.23736/s0026-4806.19.05859-2 |